Clinical Trial Update: An Extension Study to Assess Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD) [Phase 2]

View source ↗

Summary

Extension study to assess vamorolone in boys with Duchenne Muscular Dystrophy completed; results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duchenne Muscular Dystrophy

Drugs mentioned

• Vamorolone (vamorolone)

Snippet

Sponsor: ReveraGen BioPharma, Inc. | Conditions: Duchenne Muscular Dystrophy | Phase 2 | Status: COMPLETED | Results posted: 2019-07-23